NDC 70710-1726 – Nelarabine
Nelarabine 5 mg/mL · Injection · Intravenous
Product NDC70710-1726
Product details
- Brand name
- Nelarabine
- Generic name
- Nelarabine
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- Injection
- Route
- Intravenous
- Marketing category
- ANDA · ANDA215037
- Marketed since
- November 17, 2021
- Listing expires
- December 31, 2026
- Pharmacologic class
- Nucleoside Metabolic Inhibitor
Active ingredients
- Nelarabine 5 mg/mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 70710-1726-1 | 1 VIAL, SINGLE-DOSE in 1 CARTON (70710-1726-1) / 50 mL in 1 VIAL, SINGLE-DOSE | Nov 17, 2021 |
| 70710-1726-8 | 6 VIAL, SINGLE-DOSE in 1 CARTON (70710-1726-8) / 50 mL in 1 VIAL, SINGLE-DOSE | Nov 17, 2021 |
Recalls mentioning this NDC
- D-0255-2025 Mar 12, 2025 · Class II
Failed Impurities/Degradation Specifications
Other Nelarabine products
- 62332-813 Nelarabine 5 mg/mL · Injection · Alembic Pharmaceuticals Inc.
- 46708-813 Nelarabine 5 mg/mL · Injection · Alembic Pharmaceuticals Limited
- 70121-1743 Nelarabine 5 mg/mL · Injection · Amneal Pharmaceuticals LLC
- 43598-142 Nelarabine 5 mg/mL · Injection · Dr. Reddy's Laboratories, Inc.
- 68083-233 Nelarabine 5 mg/mL · Injection · Gland Pharma Limited
- 71288-165 Nelarabine 5 mg/mL · Injection · Meitheal Pharmaceuticals Inc
- 72205-154 Nelarabine 5 mg/mL · Injection · Novadoz Pharmaceuticals LLC
- 81927-111 Nelarabine 5 mg/mL · Injection · Shorla Oncology Inc.
- 81927-375 Nelarabine 5 mg/mL · Injection · Shorla Oncology Inc.
- 39822-0650 Nelarabine 5 mg/mL · Injection · XGen Pharmaceuticals DJB, Inc.
- 70771-1685 Nelarabine 5 mg/mL · Injection · Zydus Lifesciences Limited
- 70710-1839 Nelarabine 5 mg/mL · Injection · Zydus Pharmaceuticals USA Inc.